Skip Nav Destination
Close Modal
Search Results for
progressive
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Book Series
Date
Availability
1-20 of 12648 Search Results for
progressive
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
1
Sort by
Book Chapter
Series: Pediatric and Adolescent Medicine
Volume: 20
Published: 28 September 2015
10.1159/000382027
EISBN: 978-3-318-05497-2
... Abstract Progressive neuroblastoma has a high risk of disease recurrence despite cancer treatment. Most patients can be identified at the time of diagnosis either by age over 18 months and the presence of distant metastases, or by amplification of the oncogene MYCN . As the body of knowledge...
Book
Series: Pediatric and Adolescent Medicine
Volume: 20
Published: 28 September 2015
10.1159/isbn.978-3-318-05497-2
EISBN: 978-3-318-05497-2
Book Chapter
Series: Contributions to Nephrology
Volume: 181
Published: 13 May 2013
10.1159/000348460
EISBN: 978-3-318-02390-9
... Abstract IgA nephropathy (IgAN) is the most common primary glomerular disease worldwide. About 25-30% of IgAN patients will progress to end-stage kidney disease in 20-25 years. Early-onset symptoms that are highly suggestive of progressive IgAN include massive proteinuria, hypertension, renal...
Book Chapter
Series: Contributions to Nephrology
Volume: 181
Published: 13 May 2013
10.1159/000348633
EISBN: 978-3-318-02390-9
... Abstract Rapidly progressive glomerulonephritis (RPGN) is a life-threatening disease with a poor prognosis. In this review, the pathogenesis of RPGN owing to antineutrophil cytoplasmic antibody-associated crescentic glomerulonephritis and anti-GBM diseases is discussed. By the model...
Book Chapter
Series: Contributions to Nephrology
Volume: 181
Published: 13 May 2013
10.1159/000348632
EISBN: 978-3-318-02390-9
... Abstract Plasma exchange has been used for the treatment of rapidly progressive glomerulonephritis (RPGN) for more than 40 years. Its main application has been the rapid removal of special pathogenic factors that are of great importance for treatment of antiglomerular basement membrane disease...
Book Chapter
Series: Pediatric and Adolescent Medicine
Volume: 16
Published: 07 May 2012
10.1159/000332067
EISBN: 978-3-8055-9830-9
... Abstract Progressive familial intrahepatic cholestasis is a group of inherited disorders that have been identified in the last two decades. Infants presenting with mild to severe jaundice, low GGT (FIC1, FIC2), elevated serum bile acids, failure to thrive and pruritus characterise PFIC...
Book Chapter
Series: Frontiers of Neurology and Neuroscience
Volume: 25
Published: 31 March 2009
10.1159/000209493
EISBN: 978-3-8055-9024-2
Book Chapter
Book: IgA Nephropathy Today
Series: Contributions to Nephrology
Volume: 157
Published: 25 May 2007
10.1159/000102313
EISBN: 978-3-318-01467-9
... Abstract Backgrounds: Cyclophosphamide and high-dose steroids have been used as limitedinduction therapy in progressive IgA nephropathy (IgAN) to reduce the loss of renal functionand proteinuria. We evaluated the effect of cyclophosphamide pulses (CyP) and mycophenolicacid (MPA) as sequential...
Book Chapter
Book: IgA Nephropathy Today
Series: Contributions to Nephrology
Volume: 157
Published: 25 May 2007
10.1159/000102314
EISBN: 978-3-318-01467-9
... inhibit the progressive decline in renal function of patientswith progressive IgAN. Patients who had a marked linearity of decline in loss of glomerularfiltration rate (GFR), assessed by reciprocal serum creatinine plots vs. time for more thanone year, were recruited in this study if they were...
Book Chapter
Book: Renal Fibrosis
Series: Contributions to Nephrology
Volume: 139
Published: 03 June 2003
10.1159/000071733
EISBN: 978-3-318-00964-4
Book Chapter
Book: Renal Fibrosis
Series: Contributions to Nephrology
Volume: 139
Published: 03 June 2003
10.1159/000071740
EISBN: 978-3-318-00964-4
Book Chapter
Series: Advances in Oto-Rhino-Laryngology
Volume: 61
Published: 26 September 2002
10.1159/000066825
EISBN: 978-3-318-00870-8
Book
Published: 19 July 2002
10.1159/isbn.978-3-318-00869-2
EISBN: 978-3-318-00869-2
Book Chapter
Book: Hemodialysis Technology
Series: Contributions to Nephrology
Volume: 137
Published: 31 May 2002
10.1159/000060265
EISBN: 978-3-318-00851-7
Book Chapter
Book: Lipids and the Kidney
Series: Contributions to Nephrology
Volume: 120
Published: 26 June 1997
10.1159/000059817
EISBN: 978-3-318-00223-2
Book Chapter
Book: Lipids and the Kidney
Series: Contributions to Nephrology
Volume: 120
Published: 26 June 1997
10.1159/000059826
EISBN: 978-3-318-00223-2
Book Chapter
Book: Lipids and the Kidney
Series: Contributions to Nephrology
Volume: 120
Published: 26 June 1997
10.1159/000059830
EISBN: 978-3-318-00223-2
Book Chapter
Book: Lipids and the Kidney
Series: Contributions to Nephrology
Volume: 120
Published: 26 June 1997
10.1159/000059838
EISBN: 978-3-318-00223-2
Book Chapter
Series: Frontiers of Radiation Therapy and Oncology
Volume: 30
Published: 22 April 1997
10.1159/000425707
EISBN: 978-3-318-03720-3
Book Chapter
Series: Contributions to Nephrology
Volume: 118
Published: 22 April 1996
10.1159/000425067
EISBN: 978-3-318-03382-3
1